LUNGEVITY FOUNDATION

LUNGevity believes that with increased funding for research, greater awareness and empowered survivors, we will see the day when lung cancer is a chronic, treatable disease.

LUNGevity is addressing these issues by developing and implementing programs that 1) accelerate research that patients value, 2) empower patients to actively engage in their treatment decisions, and 3) identify patient preferences and challenges in areas such as treatment options and enrollment in clinical trials. We represent the patient voice through our many strategic partnerships, advisory board service and collaborations with industry, government agencies and other nonprofit organizations.

LUNGevity has gained the reputation as the go-to organization for those seeking access to lung cancer patients. Our senior management team is comprised of seasoned professionals with deep experience in the nonprofit sector. LUNGevity's reach is expansive due to participation in our Breathe Deep grassroots events program in 47 cities across the country, our survivor educational conferences, including HOPE Summit, our highly engaged online lung cancer communities, and our affiliation with the nation's leading experts in thoracic oncology.

We are a trusted partner to a wide range of organizations and government agencies, and respected for our understanding of the unmet needs of people affected by lung cancer. LUNGevity actively seeks partnerships with other advocacy organizations, health care providers and institutions, government entities and the corporate world. LUNGevity has established many rewarding relationships with corporations that support the Foundation's work and these relationships are increasingly about collaboration and less transactional in nature. As a nonprofit, we are in the unique position to bring together two important stakeholders, advocacy and industry, to partner on solutions to benefit those affected by lung cancer; these initiatives are proving to be ongoing and effective.

Research saves lives. Strategic investment in lung cancer research will ensure patients the same promise that is now available for breast, prostate, colorectal, and other cancers — earlier detection, more effective treatment options, higher quality of life, and thousands of lives saved.

LUNGevity research is 100% patient-focused. We conduct and fund research that has potential to revolutionize outcomes for those diagnosed with lung cancer.

With our strategic approach to translational research in two priority areas—finding lung cancer early and treating it more effectively—our research speeds breakthroughs to patients so people can live longer and better lives.

LUNGevity builds on the success of these research programs by partnering and collaborating with other organizations to make the greatest progress in advancing science for patients. LUNGevity collaborates with organizations like Stand Up To Cancer and American Lung Association to fund large, multi-institution early detection projects.

LUNGevity ensures research is impactful by partnering with patient groups like ALK Positive, a group of 1,000+ ALK-positive patients and their caregivers in 41 countries who are raising significant funds for research into their specific biomarker.

LUNGevity’s Patient-Focused Research Center (Patient FoRCe) is changing the paradigm in lung cancer from assumptions being made about patient preferences to evidence-based conclusions about what patients value.

LUNGevity is researching new ways to reduce health disparities in lung cancer through our Community-Based Participatory Research program, which brings together researchers and community stakeholders as equal partners in the research process.

Education and Support: The organization has helped thousands of people affected by lung cancer find the support and information they need to navigate a lung cancer diagnosis. We've matched patients and caregivers with mentors, provided lists of questions for meetings with healthcare providers, convened survivors and caregivers at educational conferences to learn about advances in medicine and ways to live better with lung cancer, and updated our constituents on the latest research and treatment advances by our awardees and other researchers. And by building and mobilizing the lung cancer community through our social media, events and conferences, we are helping to make lung cancer a national priority.

With all the educational and support resources that LUNGevity can provide patients and caregivers, we are working hard to “reach the unreached" when they need help the most. There is anecdotal evidence that most lung cancer patients aren't handed materials with educational and support resources at the time of diagnosis; we know from studies that educated patients have better outcomes. LUNGevity is working with industry and healthcare providers to solve this challenge.